Avalo Therapeutics Inc(AVTX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

AVTX Avalo Therapeutics Inc

休市中 03-20 16:00:00 EDT

13.42

-0.80

-5.63%

盘后13.42

+0.000.00%

19:47 EDT

最高14.80	最低13.19	成交量47.75万
今开13.94	昨收14.22	日振幅11.36%
总市值2.48亿	流通市值1.56亿	总股本1,851万
成交额655.08万	换手率4.12%	流通股本1,160万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"AVTX","market":"US","secType":"STK","nameCN":"Avalo Therapeutics Inc","latestPrice":13.42,"timestamp":1774036800000,"preClose":14.22,"halted":0,"volume":477507,"hourTrading":{"tag":"盘后","latestPrice":13.42,"preClose":13.42,"latestTime":"19:47 EDT","volume":4505,"amount":60462.396,"timestamp":1774050436785,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.05625879043600567,"floatShares":11601900,"shares":18512800,"eps":-8.742119,"marketStatus":"休市中","change":-0.8,"latestTime":"03-20 16:00:00 EDT","open":13.94,"high":14.8,"low":13.185,"amount":6550815.391488,"amplitude":0.113572,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-8.742119,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1774252800000},"marketStatusCode":7,"adr":0,"listingDate":1447390800000,"exchange":"NASDAQ","adjPreClose":14.22,"preHourTrading":{"tag":"盘前","latestPrice":13.9,"preClose":14.22,"latestTime":"09:26 EDT","volume":285,"amount":4040.23011,"timestamp":1774013214793,"change":-0.32,"changeRate":-0.022504,"amplitude":0.030239},"postHourTrading":{"tag":"盘后","latestPrice":13.42,"preClose":13.42,"latestTime":"19:47 EDT","volume":4505,"amount":60462.396,"timestamp":1774050436785,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.868432596406143,"optionData":{"bulkOrders":[{"symbol":"AVTX","call":false,"expireDate":1778817600000,"strike":"10.0","timestamp":1773943517009,"price":3.9,"volume":5000,"amount":1950000,"type":"-"}]},"impliedVol":1.4434,"impliedVolPercentile":0.7597},"requestUrl":"/m/hq/s/AVTX","defaultTab":"news","newsList":[{"id":"1186771355","title":"Avalo Therapeutics：截至9月30日现金及短期投资约为1.12亿美元，预计可支持到2028年","url":"https://stock-news.laohu8.com/highlight/detail?id=1186771355","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1186771355?lang=zh_cn&edition=full","pubTime":"2025-11-06 20:25","pubTimestamp":1762431910,"startTime":"0","endTime":"0","summary":"Avalo Therapeutics：截至9月30日现金及短期投资约为1.12亿美元，预计可支持到2028年","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVTX","BK4139"],"gpt_icon":0},{"id":"1135981433","title":"Avalo Therapeutics - Lotus试验纳入250名患者，预计在2026年中期发布试验的主要数据。","url":"https://stock-news.laohu8.com/highlight/detail?id=1135981433","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1135981433?lang=zh_cn&edition=full","pubTime":"2025-10-29 19:04","pubTimestamp":1761735864,"startTime":"0","endTime":"0","summary":"Avalo Therapeutics - Lotus试验纳入250名患者，预计在2026年中期发布试验的主要数据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AVTX"],"gpt_icon":0},{"id":"1169650946","title":"Avalo Therapeutics宣布完成AVTX-009治疗脓疱性汗腺炎第二阶段Lotus试验的招募","url":"https://stock-news.laohu8.com/highlight/detail?id=1169650946","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1169650946?lang=zh_cn&edition=full","pubTime":"2025-10-29 19:00","pubTimestamp":1761735632,"startTime":"0","endTime":"0","summary":"Avalo Therapeutics宣布完成AVTX-009治疗脓疱性汗腺炎第二阶段Lotus试验的招募。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVTX","BK4139"],"gpt_icon":0},{"id":"1104569500","title":"Avalo Therapeutics任命Kevin R. Lind为董事会成员","url":"https://stock-news.laohu8.com/highlight/detail?id=1104569500","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1104569500?lang=zh_cn&edition=full","pubTime":"2025-09-22 19:05","pubTimestamp":1758539131,"startTime":"0","endTime":"0","summary":"宾夕法尼亚州韦恩，2025年9月22日 — Avalo Therapeutics Inc，一家专门致力于开发基于IL-1β治疗免疫介导炎症性疾病的临床阶段生物技术公司，今日宣布任命Kevin R. Lind为董事会成员。Lind先生拥有超过20年的资本市场、战略、业务发展和公司建设领导经验，最近还指导Longboard Pharmaceuticals实现了数十亿美元的退出交易。除了在Avalo的职务外，Lind先生目前还担任Apnimed Inc的董事会主席。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","AVTX","BK4139","LENZ","BK4007"],"gpt_icon":0},{"id":"2518203857","title":"Avalo Therapeutics, Inc.盘中异动 快速上涨6.19%报8.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518203857","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518203857?lang=zh_cn&edition=full","pubTime":"2025-03-11 00:20","pubTimestamp":1741623628,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日00时20分，Avalo Therapeutics, Inc.股票出现异动，股价快速拉升6.19%。Avalo Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.32%。其相关个股中，Mineralys Therapeutics, Inc.、Checkpoint Therapeutics, Inc.、Aeon Biopharma, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Aeon Biopharma, Inc.、Scisparc Ltd.较为活跃，换手率分别为3705.04%、3188.84%、944.79%，振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 29/04/2026 、Aeon Biopharma, Inc.、Scisparc Ltd.，振幅分别为88.14%、78.32%、49.87%。Avalo Therapeutics, Inc.公司简介：Avalo Therapeutics Inc 是一家临床阶段生物技术公司，专注于免疫失调的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311002028abf33936&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311002028abf33936&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","AVTX"],"gpt_icon":0},{"id":"2517194347","title":"Avalo Therapeutics, Inc.盘中异动 下午盘急速拉升5.44%报7.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517194347","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517194347?lang=zh_cn&edition=full","pubTime":"2025-03-07 03:17","pubTimestamp":1741288628,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日03时17分，Avalo Therapeutics, Inc.股票出现异动，股价快速拉升5.44%。Avalo Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.71%。其相关个股中，Plus Therapeutics, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Aeon Biopharma, Inc.、Plus Therapeutics, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为5013.44%、3925.30%、257.97%，振幅较大的相关个股有Plus Therapeutics, Inc.、Surrozen Inc C/Wts 01/08/2031 、Tonix Pharmaceuticals Holding Corp.，振幅分别为133.94%、125.28%、71.44%。Avalo Therapeutics, Inc.公司简介：Avalo Therapeutics Inc 是一家临床阶段生物技术公司，专注于免疫失调的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307031709963c7e4e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307031709963c7e4e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","AVTX","BK4139"],"gpt_icon":0},{"id":"2517279985","title":"Avalo Therapeutics, Inc.盘中异动 股价大涨6.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517279985","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517279985?lang=zh_cn&edition=full","pubTime":"2025-03-05 04:23","pubTimestamp":1741119819,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日04时23分，Avalo Therapeutics, Inc.股票出现异动，股价急速上涨6.71%。Avalo Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.27%。其相关个股中，Rapport Therapeutics, Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Estrella Immunopharma Inc C/Wts 29/09/2028涨幅较大，Aeon Biopharma, Inc.、Protagenic Therapeutics, Inc.、Windtree Therapeutics, Inc.较为活跃，换手率分别为1327.56%、1257.46%、1219.64%，振幅较大的相关个股有Cyclacel Pharmaceuticals Inc 6% Cnv Pfd Usd、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Plus Therapeutics, Inc.，振幅分别为122.48%、68.89%、68.09%。Avalo Therapeutics, Inc.公司简介：Avalo Therapeutics Inc 是一家临床阶段生物技术公司，专注于免疫失调的治疗。Avalo 的产品线还包括 quisovalimab和 AVTX-008。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305042339989bfcc4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305042339989bfcc4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVTX","BK4139","LENZ"],"gpt_icon":0},{"id":"2516308986","title":"Avalo Therapeutics, Inc.盘中异动 早盘股价大跌5.61%报6.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516308986","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516308986?lang=zh_cn&edition=full","pubTime":"2025-03-03 23:12","pubTimestamp":1741014730,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日23时12分，Avalo Therapeutics, Inc.股票出现异动，股价大幅跳水5.61%。Avalo Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.12%。其相关个股中，Bioxcel Therapeutics, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Entero Therapeutics Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为1475.56%、131.29%、106.66%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Pliant Therapeutics, Inc.，振幅分别为177.97%、70.53%、48.34%。Avalo Therapeutics, Inc.公司简介：Avalo Therapeutics Inc 是一家临床阶段生物技术公司，专注于免疫失调的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303231210a25d4c4d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303231210a25d4c4d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVTX","BK4139","LENZ"],"gpt_icon":0},{"id":"2514320141","title":"Avalo Therapeutics, Inc.盘中异动 早盘股价大涨5.61%报6.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514320141","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514320141?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:31","pubTimestamp":1740753086,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时31分，Avalo Therapeutics, Inc.股票出现波动，股价快速上涨5.61%。Avalo Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。其相关个股中，Tc Biopharm  Plc C/Wts 10/02/2028 、Anaptysbio, Inc.、Enveric Biosciences, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Virpax Pharmaceuticals, Inc.、Enveric Biosciences, Inc.较为活跃，换手率分别为480.36%、239.12%、55.70%，振幅较大的相关个股有Trevi Therapeutics, Inc.、Enanta Pharmaceuticals, Inc.、Aardvark Therapeutics, Inc.，振幅分别为7.11%、6.58%、6.22%。Avalo Therapeutics, Inc.公司简介：Avalo Therapeutics Inc 是一家临床阶段生物技术公司，专注于免疫失调的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223126abe0ea2c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223126abe0ea2c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","AVTX"],"gpt_icon":0},{"id":"2514861570","title":"Avalo Therapeutics, Inc.盘中异动 快速跳水5.10%报6.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514861570","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514861570?lang=zh_cn&edition=full","pubTime":"2025-02-27 03:11","pubTimestamp":1740597074,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日03时11分，Avalo Therapeutics, Inc.股票出现波动，股价快速跳水5.10%。Avalo Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.60%。其相关个股中，Enveric Biosciences, Inc.、Renovaro Inc.、Nkgen Biotech Inc C/Wts 31/05/2028涨幅较大，Enveric Biosciences, Inc.、Aeon Biopharma, Inc.、Organovo Holdings, Inc.较为活跃，换手率分别为6533.97%、289.89%、257.10%，振幅较大的相关个股有Enveric Biosciences, Inc.、Renovaro Inc.、Organovo Holdings, Inc.，振幅分别为194.07%、81.11%、52.76%。Avalo Therapeutics, Inc.公司简介：Avalo Therapeutics Inc 是一家临床阶段生物技术公司，专注于免疫失调的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227031114abde2a1e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227031114abde2a1e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVTX","BK4139","LENZ"],"gpt_icon":0},{"id":"2514090328","title":"Avalo Therapeutics, Inc.盘中异动 急速下挫6.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514090328","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514090328?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:32","pubTimestamp":1740493959,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时32分，Avalo Therapeutics, Inc.股票出现异动，股价大幅跳水6.17%。Avalo Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.15%。其相关个股中，Moleculin Biotech, Inc.、Silexion Therapeutics Corp、Adial Pharmaceuticals, Inc涨幅较大，Gt Biopharma, Inc.、Moleculin Biotech, Inc.、Adial Pharmaceuticals, Inc较为活跃，换手率分别为751.75%、467.59%、235.58%，振幅较大的相关个股有Adial Pharmaceuticals, Inc、Silexion Therapeutics Corp、Maze Therapeutics, Inc.，振幅分别为20.51%、14.67%、8.87%。Avalo Therapeutics, Inc.公司简介：Avalo Therapeutics Inc 是一家临床阶段生物技术公司，专注于免疫失调的治疗。Avalo 的产品线还包括 quisovalimab和 AVTX-008。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223239962ff292&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223239962ff292&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVTX","LENZ","BK4139"],"gpt_icon":0},{"id":"2513722414","title":"Avalo Therapeutics, Inc.盘中异动 早盘股价大涨6.04%报8.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513722414","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513722414?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:36","pubTimestamp":1740407798,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时36分，Avalo Therapeutics, Inc.股票出现波动，股价快速上涨6.04%。Avalo Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.23%。其相关个股中，Pepgen Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Aditxt, Inc.、Pepgen Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为43.71%、38.00%、24.48%，振幅较大的相关个股有Pepgen Inc.、Gossamer Bio, Inc.、Summit Therapeutics Inc.，振幅分别为70.07%、14.69%、14.51%。Avalo Therapeutics, Inc.公司简介：Avalo Therapeutics Inc 是一家临床阶段生物技术公司，专注于免疫失调的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224223638a252159c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224223638a252159c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","AVTX"],"gpt_icon":0},{"id":"2513296862","title":"Avalo Therapeutics, Inc.股价上涨10.82% 市值涨901.49万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513296862","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513296862?lang=zh_cn&edition=full","pubTime":"2025-02-21 22:31","pubTimestamp":1740148296,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日22时31分，Avalo Therapeutics, Inc.股票出现异动，股价快速拉升10.82%。截至发稿，该股报7.94美元/股，成交量2338股，换手率0.02%，振幅0.63%。Avalo Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.33%。Avalo Therapeutics, Inc.公司简介：Avalo Therapeutics Inc 是一家临床阶段生物技术公司，专注于免疫失调的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223136abd7af79&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223136abd7af79&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","AVTX"],"gpt_icon":0},{"id":"2511614925","title":"Avalo Therapeutics, Inc.盘中异动 下午盘快速跳水5.30%报7.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511614925","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511614925?lang=zh_cn&edition=full","pubTime":"2025-02-15 03:47","pubTimestamp":1739562464,"startTime":"0","endTime":"0","summary":"北京时间2025年02月15日03时47分，Avalo Therapeutics, Inc.股票出现异动，股价大幅下跌5.30%。Avalo Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.56%。其相关个股中，Moleculin Biotech, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Allogene Therapeutics, Inc.涨幅较大，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为3118.38%、794.65%、623.17%，振幅较大的相关个股有Lexaria Bioscience Corp C/Wts 14/01/2026 、Moleculin Biotech, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 ，振幅分别为74.35%、71.65%、66.45%。Avalo Therapeutics, Inc.公司简介：Avalo Therapeutics Inc 是一家临床阶段生物技术公司，专注于免疫失调的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502150347449885cf96&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502150347449885cf96&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVTX","BK4139","LENZ"],"gpt_icon":0},{"id":"2509466751","title":"Avalo Therapeutics, Inc.盘中异动 早盘股价大涨5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509466751","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509466751?lang=zh_cn&edition=full","pubTime":"2025-02-05 00:15","pubTimestamp":1738685724,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日00时15分，Avalo Therapeutics, Inc.股票出现波动，股价急速拉升5.36%。Avalo Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.33%。其相关个股中，Azitra Inc、Estrella Immunopharma Inc C/Wts 29/09/2028、Evaxion Biotech As涨幅较大，Azitra Inc、Evaxion Biotech As、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为1628.85%、925.15%、449.97%，振幅较大的相关个股有Azitra Inc、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Quoin Pharmaceuticals Ltd，振幅分别为72.82%、49.88%、47.29%。Avalo Therapeutics, Inc.公司简介：Avalo Therapeutics Inc 是一家临床阶段生物技术公司，专注于免疫失调的治疗。Avalo 的产品线还包括 quisovalimab和 AVTX-008。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205001524abc23c8f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205001524abc23c8f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVTX","LENZ","BK4139"],"gpt_icon":0},{"id":"2508714122","title":"Avalo Therapeutics, Inc.盘中异动 快速下跌6.24%报7.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508714122","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508714122?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:51","pubTimestamp":1738594293,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时51分，Avalo Therapeutics, Inc.股票出现波动，股价急速下跌6.24%。Avalo Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.42%。其相关个股中，Hcw Biologics Inc.、Gh Research Plc、Invivyd, Inc.涨幅较大，Hcw Biologics Inc.、Briacell Therapeutics Corp.、Cyclerion Therapeutics, Inc.较为活跃，换手率分别为430.00%、364.05%、232.46%，振幅较大的相关个股有Hcw Biologics Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Briacell Therapeutics Corp.，振幅分别为97.05%、50.76%、36.85%。Avalo Therapeutics, Inc.公司简介：Avalo Therapeutics Inc 是一家临床阶段生物技术公司，专注于免疫失调的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020322513398797290&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020322513398797290&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVTX","LENZ","BK4139"],"gpt_icon":0},{"id":"2507620688","title":"Avalo Therapeutics, Inc.盘中异动 急速拉升5.79%报8.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507620688","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507620688?lang=zh_cn&edition=full","pubTime":"2025-01-30 23:50","pubTimestamp":1738252202,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日23时50分，Avalo Therapeutics, Inc.股票出现异动，股价快速拉升5.79%。Avalo Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.23%。其相关个股中，Tectonic Therapeutic, Inc.、Cero Therapeutics Holdings, Inc.、Kazia Therapeutics Limited涨幅较大，Kazia Therapeutics Limited、Silexion Therapeutics Corp、Alterity Therapeutics Limited较为活跃，换手率分别为1565.36%、198.84%、194.86%，振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、Alterity Therapeutics Limited、Immatics N V C/Wts 01/07/2025 ，振幅分别为61.86%、61.86%、56.41%。Avalo Therapeutics, Inc.公司简介：Avalo Therapeutics Inc 是一家临床阶段生物技术公司，专注于免疫失调的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130235002abbd5aa4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130235002abbd5aa4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","AVTX"],"gpt_icon":0},{"id":"2507543285","title":"Avalo Therapeutics, Inc.盘中异动 股价大涨7.82%报7.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507543285","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507543285?lang=zh_cn&edition=full","pubTime":"2025-01-29 00:36","pubTimestamp":1738082177,"startTime":"0","endTime":"0","summary":"北京时间2025年01月29日00时36分，Avalo Therapeutics, Inc.股票出现异动，股价大幅上涨7.82%。Avalo Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。其相关个股中，Silexion Therapeutics Corp、Transcode Therapeutics, Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 涨幅较大，Silexion Therapeutics Corp、Hepion Pharmaceuticals, Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为4376.87%、3334.29%、2454.34%，振幅较大的相关个股有Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Transcode Therapeutics, Inc.，振幅分别为176.95%、122.16%、102.05%。Avalo Therapeutics, Inc.公司简介：Avalo Therapeutics Inc 是一家临床阶段生物技术公司，专注于免疫失调的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012900361796130253&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012900361796130253&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","AVTX"],"gpt_icon":0},{"id":"2506308448","title":"Avalo Therapeutics, Inc.盘中异动 快速上涨5.52%报7.96美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506308448","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506308448?lang=zh_cn&edition=full","pubTime":"2025-01-27 22:33","pubTimestamp":1737988436,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日22时33分，Avalo Therapeutics, Inc.股票出现波动，股价快速拉升5.52%。Avalo Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.41%。其相关个股中，Akero Therapeutics, Inc.、89Bio, Inc.、Onconetix, Inc.涨幅较大，Onconetix, Inc.、Pmgc Holdings Inc.、Hepion Pharmaceuticals, Inc.较为活跃，换手率分别为730.99%、44.39%、40.37%，振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Evaxion Biotech As，振幅分别为53.75%、28.15%、18.91%。Avalo Therapeutics, Inc.公司简介：Avalo Therapeutics Inc 是一家临床阶段生物技术公司，专注于免疫失调的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127223356a2316b98&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127223356a2316b98&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","AVTX"],"gpt_icon":0},{"id":"2505170522","title":"Avalo Therapeutics, Inc.盘中异动 快速下跌5.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505170522","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505170522?lang=zh_cn&edition=full","pubTime":"2025-01-23 04:47","pubTimestamp":1737578826,"startTime":"0","endTime":"0","summary":"北京时间2025年01月23日04时47分，Avalo Therapeutics, Inc.股票出现波动，股价大幅跳水5.65%。Avalo Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.44%。其相关个股中，Nutriband Inc C/Wts 、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Nutriband Inc.涨幅较大，Immunoprecise Antibodies Ltd.、Hepion Pharmaceuticals, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为1044.12%、476.58%、104.85%，振幅较大的相关个股有Revolution Medicines Inc C/Wts 17/12/2026 、Immunoprecise Antibodies Ltd.、Eterna Therapeutics Inc.，振幅分别为68.99%、63.37%、63.32%。Avalo Therapeutics, Inc.公司简介：Avalo Therapeutics Inc 是一家临床阶段生物技术公司，专注于免疫失调的治疗。Avalo 的产品线还包括 quisovalimab和 AVTX-008。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123044706a22bfe7c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123044706a22bfe7c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","AVTX","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.avalotx.com","stockEarnings":[{"period":"1week","weight":-0.1506},{"period":"1month","weight":-0.1053},{"period":"3month","weight":-0.2785},{"period":"6month","weight":0.1344},{"period":"1year","weight":0.6326},{"period":"ytd","weight":-0.261}],"compareEarnings":[{"period":"1week","weight":-0.0207},{"period":"1month","weight":-0.055},{"period":"3month","weight":-0.047},{"period":"6month","weight":-0.0228},{"period":"1year","weight":0.1469},{"period":"ytd","weight":-0.0489}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Avalo Therapeutics, Inc.于2011年1月31日在美国特拉华州注册成立。该公司是一家生物制药公司，为在免疫学、免疫肿瘤学和罕见遗传疾病方面具有需求的患者发现、开发和商业化靶向疗法。 该公司已经建立了多样化的创新疗法组合，为急需的患者提供有意义的医疗影响。该公司的临床候选药物通常具有经过验证的机械原理、生物标志物或已建立的概念验证，以加快和增加成功的可能性。","yearOnYearQuotes":[{"month":1,"riseRate":0.363636,"avgChangeRate":-0.063135},{"month":2,"riseRate":0.454545,"avgChangeRate":-0.010519},{"month":3,"riseRate":0.272727,"avgChangeRate":0.272361},{"month":4,"riseRate":0.3,"avgChangeRate":-0.087519},{"month":5,"riseRate":0.3,"avgChangeRate":-0.069789},{"month":6,"riseRate":0.7,"avgChangeRate":0.011587},{"month":7,"riseRate":0.5,"avgChangeRate":0.025049},{"month":8,"riseRate":0.6,"avgChangeRate":-0.034606},{"month":9,"riseRate":0.6,"avgChangeRate":0.04604},{"month":10,"riseRate":0.6,"avgChangeRate":0.161359},{"month":11,"riseRate":0.4,"avgChangeRate":-0.050828},{"month":12,"riseRate":0.272727,"avgChangeRate":-0.047903}],"exchange":"NASDAQ","name":"Avalo Therapeutics Inc","nameEN":"Avalo Therapeutics Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.37.0","shortVersion":"4.37.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Avalo Therapeutics Inc(AVTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Avalo Therapeutics Inc(AVTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Avalo Therapeutics Inc,AVTX,Avalo Therapeutics Inc股票,Avalo Therapeutics Inc股票老虎,Avalo Therapeutics Inc股票老虎国际,Avalo Therapeutics Inc行情,Avalo Therapeutics Inc股票行情,Avalo Therapeutics Inc股价,Avalo Therapeutics Inc股市,Avalo Therapeutics Inc股票价格,Avalo Therapeutics Inc股票交易,Avalo Therapeutics Inc股票购买,Avalo Therapeutics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Avalo Therapeutics Inc(AVTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Avalo Therapeutics Inc(AVTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}